Weekly Roundup
COVID-19 Vaccine Development, Policy, and Public Perception in the United States
|
|
CommuniVax Corner
Dr. Monica Schoch-Spana, CommuniVax co-PI, was recently featured in a Washington Post investigation examining why Hispanic adults report some of the lowest COVID-19 vaccination rates in the U.S. despite being among the most eager to get vaccinated. Watch the video here.
The webinar will consider the impact of research and outreach in 4 local areas, which together represent a mix of Black and Hispanic/Latino communities in rural to urban areas. Local leaders and public health officials will hear about these communities and what they are doing to address COVID-19 vaccination and equity challenges..
|
|
People, Perceptions, and Polls
|
|
PODCAST
Misinformation and the COVID-19 Vaccination Campaign. Nirav Shah (Director, Maine Center for Disease Control and Prevention) and Joe Smyser (CEO, the Public Good Projects) share the latest insights from the field. Tune in to hear about Maine CDC’s social media strategy, learn about existing expertise health agencies can leverage to counter misinformation, and stay up to date with challenges at the intersect of traditional media, social media, and health information. (ASTHO, 8/25/21)
See also:
|
|
NEWS
By The Numbers: Who’s Refusing Covid Vaccinations—And Why. The fact that Covid-19 has become a “pandemic of the unvaccinated” has been well-covered, and it dominates communications from public health authorities. However, millions of Americans who are eligible for shots still choose not to get them, and FDA approval of Pfizer’s vaccine doesn’t seem to have changed the rate of vaccinations nor people’s views on getting it. Some of those sitting out the shot are adamantly opposed to the vaccine while others claim to still be on the fence. Here’s a look at the adults who are still refusing to get a Covid vaccine, according to an analysis of nationwide polls. (Forbes, 9/5/21)
|
|
NEWS
Lack of a Vaccine Mandate Becomes Competitive Advantage in Hospital Staffing Wars. The market for health care labor, strained by more than a year and a half of coping with the pandemic, continues to be pinched. While urban hospitals with deeper pockets for shoring up staff have implemented vaccine mandates, and may even use them as a selling point to recruit staffers and patients, their rural and regional counterparts are left with hard choices as cases surge again. (KHN, 8/31/21)
|
|
Law, Policy, and Politics
|
|
NEWS
Biden Will Require Vaccines For Federal Workers As Part Of A New COVID Strategy. President Biden is set to deliver remarks Thursday on what the White House calls a new six-pronged strategy to contain the delta variant of the coronavirus as cases continue to surge across the country. As part of the strategy, Biden will announce that federal workers and contractors will be required to be vaccinated for COVID-19, eliminating an option for unvaccinated workers to be regularly tested instead . (NPR 9/9/21)
|
|
Research, Development, and Clinical Practice
|
|
NEWS
We’re Asking the Impossible of Vaccines. No infection means no disease, no death, and no transmission, the absolute immunological trifecta. It’s why sterilizing immunity has often been framed as a “holy grail,” what researchers aim for when they’re designing their shots. But sterilizing immunity also has been a source of trouble . (The Atlantic, 9/9/21)
|
|
NEWS
One Vaccine Makes More Antibodies Than Another. Does it Matter? One small U.S. study found waning levels of antibodies with Pfizer’s vaccine, particularly in an older group of people. And a larger study from Belgium found that Moderna’s shot may generate more antibodies than Pfizer’s. But what this all means in the real world is still unclear. While billions of doses of vaccine have been administered around the world, researchers are still working to understand the nuances of how long their protection lasts, and how it differs from one person to another. . (Bloomberg, 9/4/21)
|
|
WEBINAR
COVID Vaccines: The Latest on Variants and Breakthrough Infections. This virtual event, featuring Drs. Amesh Adalja, Nahid Bhadelia, Akiko Iwasaki, and Marion Pepper, will convene leading scientific and medical experts to discuss the most pressing questions around COVID-19 vaccines vaccines concerning variants and breakthrough infections. A public Q&A will follow the expert discussion. The webinar will take place on Monday, September 13, 2021, 12:30-1:45 PM ET . (Aspen Institute, 9/21)
|
|
This newsletter supports CommuniVax, a research coalition convened by the
Johns Hopkins Center for Health Security and the Texas State University Department of Anthropology,
with support from the Chan Zuckerberg Initiative and The Rockefeller Foundation.
|
|
|
|
|
|
|